heiBIB: Bischoff, Helge

Bischoff, Helge Dr.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (42)
deutsch (7)

Co-Autoren (Uni Heidelberg)

mehr ...

Bozorgmehr, Farastuk (9)
Kriegsmann, Mark (8)
Winter, Hauke (8)
Eichhorn, Martin E. (8)
Kirchner, Martina (6)
Schirmacher, Peter (6)
Hoffmann, Hans (6)
Warth, Arne (6)
Schneider, Marc (6)
Penzel, Roland (5)
Kriegsmann, Katharina (5)
Endris, Volker (5)
El-Shafie, Rami (5)
Kuon, Jonas (5)
Eichhorn, Florian (5)
Kazdal, Daniel (4)
Rieken, Stefan (4)
Klotz, Laura Valentina (4)
Volckmar, Anna-Lena (4)
Schnabel, Philipp Albert (1953-2021) (3)
Reinmuth, Niels (3)
Budczies, Jan (3)
Lasitschka, Felix (3)
Stumpf, Patrick (2)
Stumpf, Andreas (2)
Neumann, Olaf (2)
Kappes, Jutta (2)
Ristau, Jonas (2)
Leichsenring, Jonas (2)
Kobinger, Sonja (2)
Magios, Nikolaus (2)
Allgäuer, Michael (2)
El Sayed, Mei (2)
(weitere Einträge vorhanden...)

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Michels, Sebastian: Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer : final results of the EUCROSS trial / S. Michels, B. Massutí, I. Vasyliv, J. Stratmann, J. Frank, A. Adams, E. Felip, C. Grohé, D. Rodrigu… , February 2024. - 10 S. : Illustrationen
In: ESMO open, ISSN 2059-7029. 9(2024), 2 vom: Feb., Artikel-ID 102237, Seite 1-10
DOI: 10.1016/j.esmoop.2024.102237
Garassino, Marina: Pembrolizumab plus pemetrexed and platinum in nonsquamous non-small-cell lung cancer : 5-year outcomes from the phase 3 KEYNOTE-189 study / Marina C. Garassino, Shirish Gadgeel, Giovanna Speranza, Enriqueta Felip, Emilio Esteban, Manuel Dóm… , April 10, 2023. - 14 S. : Illustrationen
In: Journal of clinical oncology, ISSN 1527-7755. 41(2023), 11 vom: Apr., Seite 1992-1998
DOI: 10.1200/JCO.22.01989
Garassino, Marina: Durvalumab after sequential chemoradiotherapy in stage III, unresectable NSCLC : the phase 2 PACIFIC-6 trial / Marina C. Garassino, MD, Julien Mazieres, MD, Martin Reck, MD, Christos Chouaid, MD, Helge Bischoff,… , 9 August 2022. - 13 S. : Diagramme
In: Journal of thoracic oncology, ISSN 1556-1380. 17(2022), 12 vom: Dez., Seite 1415-1427
DOI: 10.1016/j.jtho.2022.07.1148
Reck, Martin: Brief report: Exploratory analysis of maintenance therapy in patients with extensive-stage SCLC treated first line with Atezolizumab plus carboplatin and etoposide / Martin Reck, Tony S.K. Mok, Aaron Mansfield, Richard De Boer, Gyorgy Losonczy, Shunichi Sugawara, Ra… , 26 August 2022. - 8 S.
In: Journal of thoracic oncology, ISSN 1556-1380. 17(2022), 9, Seite 1122-1129
DOI: 10.1016/j.jtho.2022.05.016
Blasi, Miriam: Major clinical benefit from adjuvant chemotherapy for stage II-III non-small cell lung cancer patients aged 75 years or older : a propensity score-matched analysis / Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. H… , 28 June 2022. - 8 S.
In: BMC pulmonary medicine, ISSN 1471-2466. 22(2022), Artikel-ID 255, Seite 1-8
DOI: 10.1186/s12890-022-02043-6
Mountzios, Giannis: Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer / G. Mountzios, E. Samantas, K. Senghas, E. Zervas, J. Krisam, K. Samitas, F. Bozorgmehr, J. Kuon, S. … , 1 September 2021. - 10 S.
In: ESMO open, ISSN 2059-7029. 6(2021), 5, Artikel-ID 100254, Seite 1-10
DOI: 10.1016/j.esmoop.2021.100254
Fisch, David: Comprehensive dissection of treatment patterns and outcome for patients with metastatic large-cell neuroendocrine lung carcinoma / David Fisch, Farastuk Bozorgmehr, Daniel Kazdal, Jonas Kuon, Laura V. Klotz, Rajiv Shah, Florian Eic… , 08 July 2021. - 12 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 8. Juli, Artikel-ID 673901, Seite 1-12
DOI: 10.3389/fonc.2021.673901
Rodríguez-Abreu, Delvys: Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC : protocol-specified final analysis from KEYNOTE-189 / D. Rodríguez-Abreu, S.F. Powell, M.J. Hochmair, S. Gadgeel, E. Esteban, E. Felip, G. Speranza, F. De… , 22 April 2021. - 15 S.
In: Annals of oncology, ISSN 1569-8041. 32(2021), 7, Seite 881-895
DOI: 10.1016/j.annonc.2021.04.008
Magios, Nikolaus: Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancer / Nikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, Daniel Kazdal, Martina Kirchner, Felix J. … , March 24, 2021. - 13 S.
In: Therapeutic advances in medical oncology, ISSN 1758-8359. 13(2021) vom: Jan., Artikel-ID 1758835921996509, Seite 1-13
DOI: 10.1177/1758835921996509
Herbst, Roy S.: Phase 1 expansion cohort of ramucirumab plus pembrolizumab in advanced treatment-naive NSCLC / Roy S. Herbst, MD, PhD, Hendrik Tobias Arkenau, MD, Johanna Bendell, MD, Edward Arrowsmith, MD, Mart… , 2021. - 11 S.
In: Journal of thoracic oncology, ISSN 1556-1380. 16(2021), 2, Seite 289-298
DOI: 10.1016/j.jtho.2020.10.004
Eichhorn, Florian: Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer : first clinical experience / Florian Eichhorn, Laura V. Klotz, Mark Kriegsmann, Helge Bischoff, Marc A. Schneider, Thomas Muley, … , 21 January 2021. - 8 S.
In: Lung cancer, ISSN 1872-8332. 153(2021), Seite 150-157
DOI: 10.1016/j.lungcan.2021.01.018
Gadgeel, Shirish: Updated analysis from KEYNOTE-189 : pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer / Shirish Gadgeel, MB, BS; Delvys Rodríguez-Abreu, MD; Giovanna Speranza, MD, MSc; Emilio Esteban, MD;… , March 9, 2020. - 13 S.
In: Journal of clinical oncology, ISSN 1527-7755. 38(2020), 14 vom: Mai, Seite 1505-1517
DOI: 10.1200/JCO.19.03136
Goldman, Jonathan W.: A randomized phase III study of abemaciclib versus erlotinib in patients with stage IV non-small cell lung cancer with a detectable KRAS mutation who failed prior platinum-based therapy : JUNIPER / Jonathan W. Goldman, Julien Mazieres, Fabrice Barlesi, Konstantin H. Dragnev, Marianna Koczywas, Tun… , 26 October 2020. - 12 S.
In: Frontiers in oncology, ISSN 2234-943X. 10(2020), Artikel-ID 578756, Seite 1-12
DOI: 10.3389/fonc.2020.578756
Christopoulos, Petros: Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing / P. Christopoulos, M. Kirchner, J. Roeper, F. Saalfeld, M. Janning, F. Bozorgmehr, N. Magios, D. Kazd… , 22 August 2020. - 8 S.
In: Lung cancer, ISSN 1872-8332. 148(2020), Seite 105-112
DOI: 10.1016/j.lungcan.2020.08.007
Wessels, Sabine: Comprehensive serial biobanking in advanced NSCLC : feasibility, challenges and perspectives / Sabine Wessels, Thomas Muley, Petros Christopoulos, Michael Meister, Ingrid Heinzmann-Groth, Arne Wa… , August 2020. - 15 S.
In: Translational Lung Cancer Research, ISSN 2226-4477. 9(2020), 4, Seite 1000-1014
DOI: 10.21037/tlcr-20-137
Garassino, Marina: Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189) : a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial / Marina C. Garassino, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Giovanna Speranza, Manuel Dom… , March 2020. - 11 S.
In: The lancet, ISSN 1474-5488. 21(2020), 3, Seite 387-397
DOI: 10.1016/S1470-2045(19)30801-0
Rheinheimer, Stephan: Oligoprogressive non-small-cell lung cancer under treatment with PD-(L)1 inhibitors / Stephan Rheinheimer, Claus-Peter Heussel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, Hauke… , 23 April 2020. - 13 S.
In: Cancers, ISSN 2072-6694. 12(2020), 4, Artikel-ID 1046, Seite 1-13
DOI: 10.3390/cancers12041046
Bischoff, Helge: Kodierleitfaden für die Pneumologie 2020 : medizinische Dokumentation von Diagnosen und Leistungen / von Dr. Helge Bischoff, Dr. Nicolas Schönfeld. - 17. Auflage. -
Heidelberg: medhochzwei, 2020. - 221 Seiten, ISBN 978-3-86216-591-9
(Praxiswissen Abrechnung)
Eichhorn, Florian: Neoadjuvant anti-programmed death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC) : the NEOMUN trial / Florian Eichhorn, Laura V. Klotz, Helge Bischoff, Michael Thomas, Felix Lasitschka, Hauke Winter, Ha… , 02 May 2019. - 10 S.
In: BMC cancer, ISSN 1471-2407. 19(2019) Artikel-Nummer 413, 8 Seiten
DOI: 10.1186/s12885-019-5624-2
Bischoff, Helge: Kodierleitfaden für die Pneumologie 2019 : medizinische Dokumentation von Diagnosen und Leistungen / von Dr. Helge Bischoff, Dr. Nicolas Schönfeld. - 16. Auflage. -
Heidelberg: medhochzwei, 2019. - 209 Seiten, ISBN 978-3-86216-513-1
(Praxiswissen Abrechnung)
Kazdal, Daniel: Spatial and temporal heterogeneity of panel-based tumor mutational burden in pulmonary adenocarcinoma : separating biology from technical artifacts / Daniel Kazdal, Volker Endris, Michael Allgäuer, Mark Kriegsmann, Jonas Leichsenring, Anna-Lena Volck… , 23 July 2019. - 13 S.
In: Journal of thoracic oncology, ISSN 1556-1380. 14(2019), 11, Seite 1935-1947
DOI: 10.1016/j.jtho.2019.07.006
Papachristofilou, Alexandros: Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849(CV9202), combined with local radiation treatment in patients with stage IVnon-small cell lung cancer / Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Chris… , 08 February 2019. - 14 S.
In: Journal for ImmunoTherapy of Cancer, ISSN 2051-1426. vol. 7 (2019), 1, article number: 38, 14 Seiten
DOI: 10.1186/s40425-019-0520-5
Eichhorn, Florian: Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC) : the NEOMUN trial / Florian Eichhorn, Laura V. Klotz, Helge Bischoff, Michael Thomas, Felix Lasitschka, Hauke Winter, Ha… . -
London: BioMed Central, 2019. - 1 Online-Ressource
Michels, Sebastian: Safety and efficacy of crizotinib in patients with advanced or metastatic ROS1-rearranged lung cancer (EUCROSS) : a European phase II clinical trial / Sebastian Michels, Bartomeu Massutí, Hans-Ulrich Schildhaus, Jeremy Franklin, Martin Sebastian, Enri… , 2019. - 11 S.
In: Journal of thoracic oncology, ISSN 1556-1380. 14(2019), 7, Seite 1266-1276
DOI: 10.1016/j.jtho.2019.03.020
Christopoulos, Petros: Detection of TP53 mutations in tissue or liquid rebiopsies at progression identifies ALK+ lung cancer patients with poor survival / Petros Christopoulos, Steffen Dietz, Martina Kirchner, Anna-Lena Volckmar, Volker Endris, Olaf Neuma… , 21 January 2019. - 9 S.
In: Cancers, ISSN 2072-6694. 11(2019,1) Artikel-Nummer 124, 9 Seiten
DOI: 10.3390/cancers11010124
Papachristofilou, Alexandros: Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer / Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Chris… . -
London: BioMed Central, 2019. - 1 Online-Ressource
DOI: 10.1186/s40425-019-0520-5
Christopoulos, Petros: Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma / P. Christopoulos, M. Kirchner, F. Bozorgmehr, V. Endris, M. Elsayed, J. Budczies, J. Ristau, R. Penz… , [1 January 2019]. - 10 S.
In: International journal of cancer, ISSN 1097-0215. 144(2019), 1, Seite 190-199
DOI: 10.1002/ijc.31893
Stratmann, Jan A.: Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M‑positive non‑small cell lung cancer / Jan A. Stratmann · Sebastian Michels· Sofia Hornetz · Daniel C. Christoph, Sandra Sackman, Werner Sp… , 2018. - 7 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 144(2018), 12, Seite 2457-2463
DOI: 10.1007/s00432-018-2754-x
Bischoff, Helge: Kodierleitfaden für die Pneumologie 2018 : medizinische Dokumentation von Diagnosen und Leistungen / von Dr. Helge Bischoff, Dr. Nicolas Schönfeld. - 15. Auflage. -
Heidelberg: medhochzwei, 2018. - 203 Seiten, ISBN 978-3-86216-380-9
(Praxiswissen Abrechnung)
Gandhi, Leena: Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer / L. Gandhi, D. Rodríguez‑Abreu, S. Gadgeel, E. Esteban, E. Felip, F. De Angelis, M. Domine, P. Clinga… , April 16, 2018. - 15 S.
In: The New England journal of medicine, ISSN 1533-4406. 378(2018), 22, Seite 2078-2092
DOI: 10.1056/NEJMoa1801005
Christopoulos, Petros: Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance / Petros Christopoulos, Marc A. Schneider, Farastuk Bozorgmehr, Jonas Kuon, Walburga Engel-Riedel, Jen… , [May 2018]. - 8 S. : Illustrationen
In: Lung cancer, ISSN 1872-8332. 119(2018), Seite 48-55
DOI: 10.1016/j.lungcan.2018.03.002
Christopoulos, Petros: EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK+ non-small cell lung cancer / Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, Mei Elsayed, Martina Kirchner, Jonas Rista… , [15 June 2018]. - 10 S.
In: International journal of cancer, ISSN 1097-0215. 142(2018), 12, Seite 2589-2598
DOI: 10.1002/ijc.31275
Bischoff, Helge: Kodierleitfaden für die Pneumologie 2017 : medizinische Dokumentation von Diagnosen und Leistungen / von Dr. Helge Bischoff, Dr. Nicolas Schönfeld. - 14. Auflage. -
Heidelberg, Neckar: medhochzwei Verlag, 2017. - 203 Seiten : Diagramme, ISBN 978-3-86216-317-5
(Praxiswissen Abrechnung)
Bischoff, Helge: Kodierleitfaden für die Pneumologie 2016 : medizinische Dokumentation von Diagnosen und Leistungen / Helge Bischoff ; Nicolas Schönfeld. - 13. Aufl.. -
Heidelberg: medhochzwei, 2016. - 193 S., ISBN 978-3-86216-259-8
(Praxiswissen Abrechnung)
Bischoff, Helge: Erstlinienbehandlung mit Cisplatin/Pemetrexed/Bevacizumab beim Pleuramesotheliom : Ergebnisse einer Phase-III-Studie / Helge G. Bischoff, 7. Juni 2016. - 2 S.
In: Der Onkologe, ISSN 1433-0415. 22(2016), 8, Seite 598-599
DOI: 10.1007/s00761-016-0066-9
Bernhardt, Denise: Nine-year experience : prophylactic cranial irradiation in extensive disease small-cell lung cancer / Denise Bernhardt, Sebastian Adeberg, Farastuk Bozorgmehr, Nils Opfermann, Juliane Hoerner-Rieber, Mi… , 2017. - 5 S.
In: Clinical lung cancer, ISSN 1938-0690. 18(2017), 4, Seite e267-e271
DOI: 10.1016/j.cllc.2016.11.012
Yamauchi, Yoshikane: The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients : experiences at a single institution / Yoshikane Yamauchi, Thomas Muley, Seyer Safi, Stefan Rieken, Helge Bischoff, Jutta Kappes, Arne Wart… , 15 September 2015. - 6 S.
In: Lung cancer, ISSN 1872-8332. 90(2015), 2, Seite 224-229
DOI: 10.1016/j.lungcan.2015.09.010
Muley, Thomas: Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer / Thomas R. Muley, Maria Sianidou, Michael Thomas, Helge Bischoff, Hendrik Dienemann, Michael Meister,… , 2014. - 7 S.
In: Anticancer research, ISSN 1791-7530. 34(2014), 7, Seite 3707-3713
Reinmuth, Niels: Characteristics of lung cancer after a previous malignancy / Niels Reinmuth, Patrick Stumpf, Andreas Stumpf, Thomas Muley, Sonja Kobinger, Hans Hoffmann, Felix J… , 5 March 2014. - 8 S.
In: Respiratory medicine, ISSN 1532-3064. 108(2014), 6, Seite 910-917
DOI: 10.1016/j.rmed.2014.02.015
Reinmuth, Niels: Characteristics and outcome of patients with second primary lung cancer / Niels Reinmuth, Andreas Stumpf, Patrick Stumpf, Thomas Muley, Sonja Kobinger, Hans Hoffmann, Felix J… , 2013. - 9 S.
In: The European respiratory journal, ISSN 1399-3003. 42(2013), 6, Seite 1668-1676
DOI: 10.1183/09031936.00022512
Gottschling, Sandra: The gefitinib long-term responder (LTR) - a cancer stem-like cell story? : Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP) / Sandra Gottschling, Esther Herpel, Wilfried E. E. Eberhardt, David F. Heigener, Jürgen R. Fischer, C… , July 2012. - 9 S.
In: Lung cancer, ISSN 1872-8332. 77(2012), 1, Seite 183-191
DOI: 10.1016/j.lungcan.2012.03.003
Bischoff, Helge: Response to Letter to the editor / Helge G. Bischoff, David F. Heigener, Stefan Walzer, Mark Nuijten, 2011. - 1 S.
In: Lung cancer, ISSN 1872-8332. 71(2011), 2 vom: Feb., Seite 245
DOI: 10.1016/j.lungcan.2010.11.016
Banz, Kurt: Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain / Kurt Banz, Helge Bischoff, Matthias Brunner, Christos Chouaid, Javier de Castro Carpeño, Filippo de … , 17 May 2011. - 6 S.
In: Lung cancer, ISSN 1872-8332. 74(2011), 3 vom: Dez., Seite 529-534
DOI: 10.1016/j.lungcan.2011.04.010
Steins, Martin: Targeting the epidermal growth factor receptor in non-small cell lung cancer / Martin B. Steins, Niels Reinmuth, Helge Bischoff, Markus Kindermann, Michael Thomas, November 26 2010. - 6 S.
In: Onkologie, ISSN 1423-0240. 33(2010), 12, Seite 704-709
DOI: 10.1159/000322214
Nuijten, Marcus Johannes Catharina: Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” / Mark Nuijten, David F. Heigener, Helge G. Bischoff, Christos Chouaid, Alain Vergnenègre, Javier de C… , 25 September 2010. - 1 S.
In: Lung cancer, ISSN 1872-8332. 70(2010), 2 vom: Nov., Seite 230
DOI: 10.1016/j.lungcan.2010.09.007
Nuijten, Marcus Johannes Catharina: Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer / Mark Nuijten, David F. Heigener, Helge G. Bischoff, Christos Chouaid, Alain Vergnenègre, Javier de C… , 18 August 2010. - 9 S.
In: Lung cancer, ISSN 1872-8332. 69(2010), Suppl. 1$m8, Seite S4-S10
DOI: 10.1016/S0169-5002(10)70132-X
Douillard, Jean-Yves: Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer : data from the randomized phase III INTEREST trial / Jean-Yves Douillard, Frances A. Shepherd, Vera Hirsh, Tony Mok, Mark A. Socinski, Radj Gervais, Mei-… , 2010. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 28(2010), 5, Seite 744-752
DOI: 10.1200/JCO.2009.24.3030
Bischoff, Helge: Observation of the treatment and outcomes of patients receiving chemotherapy for advanced NSCLC in Europe (ACTION study) / Helge G. Bischoff, Ben van den Borne, Francisco L. Pimentel, Jorge Arellano, Frank Langer, Monika I.… , 15 Apr 2010. - 10 S.
In: Current medical research and opinion, ISSN 1473-4877. 26(2010), 6, Seite 1461-1470
DOI: 10.1185/03007991003799180
Bischoff, Helge: Chemotherapie eines Nitrosamin-induzierten autochthonen Colontumors bei SD-Ratten mmit -Diketonato-Verbindungen von Titan, Zirkonium und Hafnium, im Vergleich mit cis-Platin, Cyclophosphamid, 5-Fluorouracil und 5'Deoxy-5-Fluorouridin / Helge G. Bischoff, 1986. - 144 Bl. : graph. Darst.

IDs

GND:

111184576

Links

Bischoff, Helge in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design